SenesTech, Inc. (SNES)
NASDAQ: SNES · Real-Time Price · USD
1.620
-0.100 (-5.81%)
At close: May 15, 2026, 4:00 PM EDT
1.660
+0.040 (2.47%)
After-hours: May 15, 2026, 7:37 PM EDT
Company Description
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control.
The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption.
It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice.
The company was incorporated in 2004 and is headquartered in Surprise, Arizona.
SenesTech, Inc.
| Country | United States |
| Founded | 2004 |
| IPO Date | Dec 8, 2016 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 24 |
| CEO | Michael Edell |
Contact Details
Address: 13430 North Dysart Road, Suite 105 Surprise, Arizona 85379 United States | |
| Phone | 928 779 4143 |
| Website | senestech.com |
Stock Details
| Ticker Symbol | SNES |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001680378 |
| CUSIP Number | 81720R208 |
| ISIN Number | US81720R6045 |
| Employer ID | 20-2079805 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Thomas C. Chesterman M.B.A. | Executive Vice President, Chief Financial Officer, Treasurer and Secretary |
| Bryan Di Menna | Vice President of Sales |
| Robert Blum | Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 13, 2026 | 10-Q | Quarterly Report |
| May 12, 2026 | 8-K | Current Report |
| May 7, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| May 7, 2026 | 8-K | Current Report |
| Apr 29, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 29, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 18, 2026 | SCHEDULE 13G/A | Filing |
| Mar 13, 2026 | 10-K | Annual Report |
| Mar 12, 2026 | 8-K | Current Report |
| Feb 2, 2026 | SCHEDULE 13G/A | Filing |